Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …

COVID-19 outcomes in people with cystic fibrosis : Current Opinion in Pulmonary Medicine
COVID-19 outcomes in people with cystic fibrosis : Current Opinion in Pulmonary Medicine Log …

Background Depression and anxiety are two to four times more prevalent in people with CF
(pwCF) than the general population. COVID-19 may exacerbate mental health challenges …

Abstract Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a recently approved cystic fibrosis (CF)
transmembrane conductance regulator modulator therapy that has shown promising clinical …

Background Postural and aerobic exercises are essential in rehabilitation in cystic fibrosis
(CF). The aim of this study is to examine the effect of telerehabilitation on the quality of life …

Background The COVID‐19 pandemic impacted many households due to shelter‐in‐place
orders and economic hardship. People with cystic fibrosis (CF) experienced increased food …

Background Little is known about the impact of COVID‐19 and the United Kingdom's (UK)
national shielding advice on people with cystic fibrosis (CF) and their families. This study …

Strict isolation of vulnerable individuals has been a strategy implemented by authorities to
protect people from COVID‐19. Our objective was to investigate health‐related quality of life …

Research shows that people with cystic fibrosis are more prone to suffer from psychological
problems than healthy people; thus, the outbreak of the COVID-19 pandemic in Poland …

Background We have recently reported reduced physical activity (PA) in people with cystic
fibrosis (pwCF) with and without lung transplantation (LTX) during a 6-week stringent …